MedCap AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was SEK 766.3 million compared to SEK 546.9 million a year ago. Revenue was SEK 774 million compared to SEK 552 million a year ago. Net income was SEK 71.6 million compared to SEK 40.6 million a year ago. Basic earnings per share from continuing operations was SEK 4.8 compared to SEK 2.7 a year ago. Diluted earnings per share from continuing operations was SEK 4.8 compared to SEK 2.7 a year ago.